87 related articles for article (PubMed ID: 10884506)
1. Eriochrome Black T inhibits endothelial cell growth through S-phase blockade.
Langer I; Atassi G; Robberecht P; Résibois A
Eur J Pharmacol; 2000 Jul; 399(2-3):85-90. PubMed ID: 10884506
[TBL] [Abstract][Full Text] [Related]
2. Eriochrome Black T, structurally related to suramin, inhibits angiogenesis and tumor growth in vivo.
Morris AD; Léonce S; Guilbaud N; Tucker GC; Pérez V; Jan M; Cordi AA; Pierré A; Atassi G
Anticancer Drugs; 1997 Sep; 8(8):746-55. PubMed ID: 9396618
[TBL] [Abstract][Full Text] [Related]
3. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21(Waf1/Cip1) and p27(Kip1) in urothelial carcinoma: correlation with other cell-cycle-related proteins (Rb, p53, Ki-67 and PCNA) and clinicopathological features.
Ioachim E; Michael M; Stavropoulos NE; Kitsiou E; Hastazeris K; Salmas M; Stefanaki S; Agnantis NJ
Urol Int; 2004; 73(1):65-73. PubMed ID: 15263796
[TBL] [Abstract][Full Text] [Related]
4. Delphinidin inhibits endothelial cell proliferation and cell cycle progression through a transient activation of ERK-1/-2.
Martin S; Favot L; Matz R; Lugnier C; Andriantsitohaina R
Biochem Pharmacol; 2003 Feb; 65(4):669-75. PubMed ID: 12566096
[TBL] [Abstract][Full Text] [Related]
5. Plasmin-clipped beta(2)-glycoprotein-I inhibits endothelial cell growth by down-regulating cyclin A, B and D1 and up-regulating p21 and p27.
Beecken WD; Ringel EM; Babica J; Oppermann E; Jonas D; Blaheta RA
Cancer Lett; 2010 Oct; 296(2):160-7. PubMed ID: 20435405
[TBL] [Abstract][Full Text] [Related]
6. Curcumin inhibits the proliferation and cell cycle progression of human umbilical vein endothelial cell.
Singh AK; Sidhu GS; Deepa T; Maheshwari RK
Cancer Lett; 1996 Oct; 107(1):109-15. PubMed ID: 8913274
[TBL] [Abstract][Full Text] [Related]
7. Bladder epithelial cell proliferation of rats induced by terephthalic acid-calculi.
Dai G; Cui L; Song L; Cheng J; Zhong Y; Zhao R; Wang X
Food Chem Toxicol; 2005 Feb; 43(2):217-24. PubMed ID: 15621333
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effects of 1alpha,25-dihydroxyvitamin D(3) on the G(1)-S phase-controlling machinery.
Jensen SS; Madsen MW; Lukas J; Binderup L; Bartek J
Mol Endocrinol; 2001 Aug; 15(8):1370-80. PubMed ID: 11463860
[TBL] [Abstract][Full Text] [Related]
9. Cyclin D1 inhibits cell proliferation through binding to PCNA and cdk2.
Fukami-Kobayashi J; Mitsui Y
Exp Cell Res; 1999 Feb; 246(2):338-47. PubMed ID: 9925749
[TBL] [Abstract][Full Text] [Related]
10. Loss of cyclin D1 does not inhibit the proliferative response of mouse liver to mitogenic stimuli.
Ledda-Columbano GM; Pibiri M; Concas D; Cossu C; Tripodi M; Columbano A
Hepatology; 2002 Nov; 36(5):1098-105. PubMed ID: 12395319
[TBL] [Abstract][Full Text] [Related]
11. PCNA/cyclin expression and BrdU uptake define different subpopulations in different cell lines.
Coltrera MD; Gown AM
J Histochem Cytochem; 1991 Jan; 39(1):23-30. PubMed ID: 1670579
[TBL] [Abstract][Full Text] [Related]
12. Anti-proliferation effect of 5,5-diphenyl-2-thiohydantoin (DPTH) in human vascular endothelial cells.
Shih CR; Wu J; Liu Y; Liang YC; Lin SY; Sheu MT; Lee WS
Biochem Pharmacol; 2004 Jan; 67(1):67-75. PubMed ID: 14667929
[TBL] [Abstract][Full Text] [Related]
13. Expression of the G1-S modulators in hepatitis B virus-related hepatocellular carcinoma and dysplastic nodule: association of cyclin D1 and p53 proteins with the progression of hepatocellular carcinoma.
Choi YL; Park SH; Jang JJ; Park CK
J Korean Med Sci; 2001 Aug; 16(4):424-32. PubMed ID: 11511787
[TBL] [Abstract][Full Text] [Related]
14. Effects of suramin on expression of proliferation associated nuclear antigens in DU-145 prostate carcinoma cells.
Qiao L; Pizzolo JG; Melamed MR
Biochem Biophys Res Commun; 1994 Jun; 201(2):581-8. PubMed ID: 7911660
[TBL] [Abstract][Full Text] [Related]
15. Rapamycin (sirolimus) inhibits proliferating cell nuclear antigen expression and blocks cell cycle in the G1 phase in human keratinocyte stem cells.
Javier AF; Bata-Csorgo Z; Ellis CN; Kang S; Voorhees JJ; Cooper KD
J Clin Invest; 1997 May; 99(9):2094-9. PubMed ID: 9151781
[TBL] [Abstract][Full Text] [Related]
16. Antimitogenic and proapoptotic activities of methylseleninic acid in vascular endothelial cells and associated effects on PI3K-AKT, ERK, JNK and p38 MAPK signaling.
Wang Z; Jiang C; Ganther H; Lü J
Cancer Res; 2001 Oct; 61(19):7171-8. PubMed ID: 11585751
[TBL] [Abstract][Full Text] [Related]
17. Loss of cyclin A and G1-cell cycle arrest are a prerequisite of ceramide-induced toxicity in human arterial endothelial cells.
Spyridopoulos I; Mayer P; Shook KS; Axel DI; Viebahn R; Karsch KR
Cardiovasc Res; 2001 Apr; 50(1):97-107. PubMed ID: 11282082
[TBL] [Abstract][Full Text] [Related]
18. T-cadherin upregulation correlates with cell-cycle progression and promotes proliferation of vascular cells.
Ivanov D; Philippova M; Allenspach R; Erne P; Resink T
Cardiovasc Res; 2004 Oct; 64(1):132-43. PubMed ID: 15364621
[TBL] [Abstract][Full Text] [Related]
19. Proliferation markers, proliferating cell nuclear antigen, Ki67, 5-bromo-2'-deoxyuridine, and cyclin D1 in mouse olfactory epithelium.
Ohta Y; Ichimura K
Ann Otol Rhinol Laryngol; 2000 Nov; 109(11):1046-8. PubMed ID: 11089996
[TBL] [Abstract][Full Text] [Related]
20. Bone morphogenetic protein-2 blocks MDA MB 231 human breast cancer cell proliferation by inhibiting cyclin-dependent kinase-mediated retinoblastoma protein phosphorylation.
Ghosh-Choudhury N; Woodruff K; Qi W; Celeste A; Abboud SL; Ghosh Choudhury G
Biochem Biophys Res Commun; 2000 Jun; 272(3):705-11. PubMed ID: 10860819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
